Tuesday, 31 March 2020

Japan News

  • Chugai, Nippon Shinyaku tie up for drug development

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: Tokyo-headquartered Chugai Pharmaceutical and Kyotobased Nippon Shinyaku have entered into an agreement to co-develop and co-market GA101 (obinutuzumab), the first glycoengineere...Read more

  • INC Research opens two new offices in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Jul, 2013

    Singapore: INC Research, a therapeutically focused global clinical research organization (CRO) with a Trusted Process(R) for delivering reliable results, announced the establishment of INC ...Read more

  • Deregulation will boost Japanese pharma sector

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Jun, 2013

    Singapore: Japan's pharmaceutical industry is the second largest in the world, worth $89 billion in 2011 or 10 percent of the world market. The industry grew from $62.8 billion in 2005 to i...Read more

  • Takeda gets FDA nod for three diabetes drugs

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 04 Feb, 2013

    Singapore: Japan-headquartered Takeda Pharmaceutical received the US Food and Drug Administration (FDA) approval for Nesina (alogliptin) and the fixed-dose combination (FDC) therapies Oseni...Read more

  • Teva appoints new chairman for Japan, South Korea

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 13 Sep, 2012

    Singapore: Teva Pharmaceutical has appointed Professor Itzhak Krinsky as chairman of Teva Japan and Teva South Korea and head of Business Development Asia-Pacific. Currently serving as exec...Read more

  • Germany seeks closer partnership with Japan in biopharma

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 09 Oct, 2012

    Singapore: Germany Trade & Invest and the Health-Made in Germany initiative will join forces at this year's BioJapan 2012 from October 10-12. Representatives from German and Japanese bi...Read more

  • Interphex Japan: Japan pharma eyes China, India

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 10 Jul, 2013

    Tokyo: The 7th in-Pharma Japan and 26th Interphex Japan, which are being concurrently held at Tokyo Big Sight, Japan, kick started with much pomp and grandeur. The keynote address, which f...Read more

  • Daiichi may take legal action against ex-Ranbaxy promoters

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 May, 2013

    Singapore: Breaking its silence for the first time in 10 days after Indian drug major Ranbaxy's $500 million settlement of the US Food and Drug Administration (FDA) felony charges over drug...Read more

  • Free software creates largest neural simulation

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Aug, 2013

    Singapore: Researchers from the Riken HPCI Program for Computational Life Sciences, the Okinawa Institute of Technology Graduate University in Japan and Forschungszentrum Jülich in Germ...Read more

  • Seegene and Eidia to bring MoDx tests to Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jul, 2013

    Singapore: Seegene, a leading developer of multiplexed molecular technologies and diagnostic tests, has entered into a collaboration agreement with Eidia, the in vitro diagnostics subsidiar...Read more

  • Reverse Medical announces alliance in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 12 Jun, 2013

    Singapore: Reverse Medical announced entering into a strategic partnership agreement with Century Medical (CMI), for distribution of the Reverse Medical products in Japan. CMI, a subsidiary...Read more

  • FDA accepts Astellas' NDA for organ rejection drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 05 Dec, 2012

    Singapore: Astellas Pharma, US, a US subsidiary of Tokyo-based Astellas Pharma, received US FDA acceptance for review of the company's New Drug Application (NDA) for tacrolimus extended re...Read more

  • Dainippon, Nippon Shinyaku sign deal for new drug

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 18 Mar, 2013

    Singapore: Dainippon Sumitomo Pharma (DSP), headquartered in Japan, and Nippon Shinyaku, also a Japanese company, have concluded a license agreement for exclusive rights to develop, manufac...Read more

  • Takeda drug Azilva launched in Japan

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 29 May, 2012

    Singapore: Takeda Pharmaceutical's Azilva (azilsartan) is now available for the treatment of hypertension in Japan. Discovered by Takeda, azilsartan is an angiotensin II receptor blocker (A...Read more

  • Japan approves Humira for Crohn's disease patients

    Japan |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 30 Oct, 2012

    Singapore: Japan's Ministry of Health, Labor and Welfare has approved the use of Humira in induction and maintenance of clinical remission in patients with moderately to severely active Cro...Read more

  • Takeda asks judge to rule in its favor

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 30 Apr, 2013

    Singapore: Takeda Pharmaceuticals, US, highlighted that in the case against Jack Cooper (No CGC-12-518535) the jury ruled in favor of the plaintiffs and awarded a total of $6.5 million in d...Read more

  • Life Tech, Japanese firm to launch stem cell kit

    Japan |  News | By BioSpectrum Bureau  | 0 Comment | 24 Oct, 2013

    Singapore: Life Technologies has extended its collaborative agreement with Japanese firm DNAVec Corporation to launch CytoTune-iPS 2.0 Sendai Reprogramming Kit, the next-generation research...Read more

  • Telemedicine is revolutionizing healthcare access

    Japan |  Analysis | By BioSpectrum Bureau  | 1 Comment | 30 Nov, 2012

    Telemedicine is re-defining access to healthcare in many ways. It has, in particular, proved to be an effective solution in providing specialty healthcare, improving access and reducing cos...Read more